Patents by Inventor Martin Brandl

Martin Brandl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140167303
    Abstract: A pressing tool for pressing a silicone element may include: an upper pressing tool half and a lower pressing tool half, which in the closed state of the pressing tool form a cavity for pressing a silicone element, and a carrier foil, which bears on one of the pressing tool halves, for the silicone element to be pressed, wherein at least the upper pressing tool half or the lower pressing tool half has at least one clamping element for aligning the two pressing tool halves with respect to one another, and wherein the clamping element is arranged between the pressing tool halves and outside the region covered by the carrier foil.
    Type: Application
    Filed: August 31, 2012
    Publication date: June 19, 2014
    Applicant: OSRAM Opto Semiconductors GmbH
    Inventors: Markus Boss, Martin Brandl, Markus Pindl
  • Publication number: 20130309788
    Abstract: A leadframe for producing a number of optoelectronic components is specified. At least one mounting region includes a number of chip mounting areas for a number of semiconductor chips. Alongside the mounting region at at least one main area of the leadframe one or more of grooves for reducing mechanical stresses in the leadframe are formed. The groove(s) do not completely penetrate through the leadframe. A method for producing a number of optoelectronic components on a leadframe of this type is furthermore specified.
    Type: Application
    Filed: January 31, 2012
    Publication date: November 21, 2013
    Applicant: OSRAM OPTO SEMICONDUCTORS GMBH
    Inventors: Martin Brandl, Tobias Gebuhr, Markus Pindl, Albert Schneider
  • Publication number: 20110208105
    Abstract: The invention relates to a device for the citrate anti-coagulated extracorporeal blood purification comprising: an extracorporeal blood purification system comprising an extracorporeal blood circuit (202), which comprises a dialysis unit (205), a blood inflow (203) and a blood discharge (204), a citrate metering device (212) for supplying citrate at a citrate supply point (213) upstream of the dialysis unit (205), a substitution medium metering device (214) for supplying a substitution medium at a substitution medium supply point (215) downstream from the dialysis unit (205), at least one ion concentration measuring means (224) for measuring bivalent cations and a controller (225), wherein the controller (225) is adapted to regulate the metering of the substitution medium as a function of a comparison between a setpoint value range and the ion concentration measured by means of the ion concentration measuring means (224), wherein the ion concentration measuring means (224) is adapted for the continuous genera
    Type: Application
    Filed: August 28, 2008
    Publication date: August 25, 2011
    Inventors: Martin Brandl, Jens Hartmann, Karin Strobl, Dieter Falkenhagen
  • Patent number: 6399094
    Abstract: A liposomal vesicular preparation with good encapsulation efficiency for active ingredients, based on homogeneous unilamellar liposomal vesicular lipids, has a substantially tightly packed vesicular structure and forms carriers of active ingredients. At least 20% by weight relative to the total weight of the liposomal vesicular preparation of the active ingredient (drug substances, vaccines, diagnostics, vectors) are present in encapsulated form inside the homogeneous unilamellar liposomal vesicular lipids. The liposomal vesicular preparation is a semi-solid liposomal vesicular lipid gel. The membrane forming amphiphiles can be members of from the group consisting of lipids, phospholipids and synthetic amphiphiles.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: June 4, 2002
    Assignees: Max-Delbrück-Centrum für Molekulare Medizin
    Inventors: Martin Brandl, Dieter Bachmann, Regine Reszka, Markus Drechsler
  • Patent number: 6090955
    Abstract: The aim of the invention is to produce liposome-encapsulated taxol with a high taxol concentration and high stability and hence a high therapeutic effect. The invention involves the development of specific forms of taxol encapsulation and the use of these, optionally in combination with other substances, in the treatment of various types of tumor. The liposome-encapsulated taxol is characterized in that it is prepared by high-pressure homogenization or by aerosol formulation.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: July 18, 2000
    Assignee: Max-Delbruck-Centrum fur Molekulare Medizin
    Inventors: Regine Reszka, Martin Brandl, Iduna Fichtner, Gernot Warnke